Latest News

Recent trading context for Bayerische Motoren Werke Bayerische Motoren Werke (XTRA:BMW) has recently drawn attention after a stretch of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months despite a slightly positive 1 year total return. See our latest analysis for Bayerische Motoren Werke. The recent 30 day share price return of 17.47% and 90 day share price return of 19.08% to a last close of €75.76 contrasts with a modest 1 year...

Framing the recent move in Bank of China shares Bank of China (SEHK:3988) has stayed on investors’ radar after recent share price moves, with returns of 0.6% over the past day and 3.3% over the past week drawing attention to its fundamentals. See our latest analysis for Bank of China. At the current share price of HK$4.7, the recent 3.3% 7 day share price return continues a trend that has given Bank of China a 6.3% 90 day share price return and an 8.3% 1 year total shareholder return. This...

ZenaTech, Inc. recently detailed that its ZenaDrone subsidiary is developing the Interceptor P-1, a single-use autonomous VTOL drone targeting a selling price under US$5,000 as part of its counter-UAS ecosystem for U.S. and allied defense forces. Alongside progress on its IQ Glider marine launch and refueling station and ZenaDrone 2000 interceptor, the company is aiming to offer a low-cost “drone-on-drone” defense architecture addressing the cost imbalance between cheap enemy drones and...

Why Graham Holdings Is on Investors’ Radar Today Graham Holdings (GHC) has drawn fresh attention after recent trading left the stock with mixed return patterns across different time frames, prompting investors to reassess how its diversified business fits into their portfolios. See our latest analysis for Graham Holdings. The recent 1-day share price decline of 2.58%, alongside weaker 7-day and 30-day share price returns, contrasts with Graham Holdings’ stronger 1-year and multi year total...

A new lawsuit accuses Paramount executive Jeff Shell of breach of verbal contract and fraud. The filing centers on alleged commitments involving senior figures at Paramount Skydance (NasdaqGS:PSKY). The case introduces fresh questions around governance and executive conduct at the combined company. Paramount Skydance, which brings together a large film, TV and streaming portfolio, sits in a sector where reputation and relationships carry real commercial weight. Studios and streaming...

Galderma Group (SWX:GALD) has scheduled a virtual Annual General Meeting that will focus on corporate governance changes. The AGM agenda includes new board nominations linked to major shareholder L’Oréal and a proposed dividend. Management plans to discuss L’Oréal’s influence as an investor following a period of record company performance. Galderma Group operates in the dermatology and skincare segment, an area that continues to attract consumer interest as spending on skin health and...

If you are wondering whether GPGI is attractively priced or already reflecting a lot of optimism, the current share price at US$17.06 raises some useful questions about what you are really paying for. Recent returns are mixed, with the stock up 3.3% over the last week but showing a 27.4% decline over 30 days, an 8.6% decline year to date, and gains of 51.0% over 1 year, 191.8% over 3 years, and 114.8% over 5 years. These moves sit against a backdrop of ongoing coverage that keeps GPGI on...

Novo Nordisk (CPSE:NOVO B) is back in focus after the FDA cleared its high dose Wegovy HD in the US, while patent protection for semaglutide in India expires, opening the door to lower cost rivals. See our latest analysis for Novo Nordisk. The FDA approval for Wegovy HD arrives at a time when short term sentiment has cooled, with a 30 day share price return of 23.72% and a 1 year total shareholder return decline of 53.81%, suggesting recent momentum has faded despite longer term gains over 5...

Why Amphenol’s latest quarter is drawing fresh investor attention Amphenol (APH) is back in focus after its latest quarter, with revenue and earnings coming in above both company guidance and external expectations, supported by expanded capacity and strong demand in defense, commercial aerospace, and data communications. See our latest analysis for Amphenol. Even after the post earnings jump mentioned earlier, the share price has recently cooled, with a 14.21% 1 month share price decline and...

Vallourec announced that it has secured a contract with BP Berau Ltd. to supply premium corrosion-resistant alloy pipes, VAM® connections, and lifecycle tubular services for the Tangguh offshore carbon capture and storage project in Papua Barat, Indonesia. This win underlines Vallourec’s growing role as a technology partner for complex CCS developments, potentially deepening its exposure to energy transition infrastructure beyond traditional oil and gas applications. We’ll now explore how...

Oklo (NYSE:OKLO) and Centrus Energy announced plans to explore a joint venture to integrate advanced nuclear fuel cycle services. The proposed venture would create a centralized deconversion hub and fuel cycle infrastructure for HALEU at Centrus's Piketon, Ohio site. The partnership targets a more coordinated domestic supply chain for advanced nuclear fuel and reactor deployment in the U.S. Oklo, trading at $53.97, sits at the center of growing attention around advanced nuclear...

In March 2026, CNOOC awarded SLB OneSubsea a multi-well, integrated subsea engineering and production contract for 20 wells at the deepwater Kaiping 18-1 field in the South China Sea, covering standardized subsea systems, installation, and commissioning support. An interesting angle is SLB OneSubsea’s simplified, standardized subsea architecture and in-country manufacturing push, which aims to cut complexity, compress installation timelines, and support future field expansions for...

In March 2026, Arcutis Biotherapeutics reported that Pediatric Dermatology published long-term Phase 3 extension data showing once-daily ZORYVE 0.05% cream remained safe, well-tolerated, and increasingly effective over 56 weeks in children aged 2 to 5 with mild-to-moderate atopic dermatitis, supporting its October 2025 FDA approval. The findings highlight durable disease control and low local irritation in a young pediatric group that often has limited non-steroidal, long-term treatment...

If you have been wondering whether Magnum Ice Cream at €12.88 is priced attractively or not, this article will walk through what that number could really mean for you as a shareholder. Over the short term, the share price has been soft, with a 4.6% decline over the last 7 days, a 4.4% decline over the last 30 days and a 3.1% decline year to date, which may change how investors think about both risk and opportunity. Recent coverage around consumer brands and listed food businesses has focused...

DiaSorin is expanding its US hospital footprint through new distribution agreements with Fisher Scientific and McKesson. The company is restructuring its China operations, including the closure of its Shanghai manufacturing site. These moves reshape DiaSorin's global setup and could influence how its immuno franchise is positioned in key markets. DiaSorin (BIT:DIA), trading at around €63.76, has been under pressure, with the share price down 32.0% over the past year and 51.7% over five...

FDA grants premarket approval to LivaNova's aura6000 System for adult patients with moderate to severe Obstructive Sleep Apnea who do not benefit from standard therapies. The system uses proximal hypoglossal nerve stimulation and is supported by clinical trial data showing meaningful outcomes, including in harder to treat patient groups. LivaNova (NasdaqGS:LIVN) also discloses work on a next generation, MRI compatible version of the aura6000 with additional features. LivaNova, listed on...

Event context and recent share performance Honeywell International (HON) shares recently closed at US$221.50, with a return of about 13.1% year to date and 14.3% over the past year, while the past month shows an 8.1% decline. See our latest analysis for Honeywell International. For Honeywell, the recent 8.1% 1 month share price decline comes after an 11.2% 3 month share price return and a 14.3% 1 year total shareholder return, so shorter term momentum is fading against a stronger longer term...

Why Sportradar’s latest earnings and deal activity matter for investors Sportradar Group (SRAD) recently reported 2025 earnings, with revenue up 17% to €1,290 million, supported by US growth and a 109% customer net retention rate. The company also closed the IMG ARENA acquisition. The company extended its exclusive data partnership with MLB for 8 years and added new rights with FIFA and the German DFB Cup, expanding coverage to more than 1 million sporting events each year. See our latest...

In March 2026, AtkinsRéalis Group Inc. announced it is collaborating with NVIDIA to explore integrating NVIDIA Omniverse, accelerated compute, and OpenUSD into the planning, design, and delivery of nuclear-powered, large-scale AI factories using 3D digital twins. This collaboration links AtkinsRéalis’ CANDU nuclear power capabilities with NVIDIA’s AI and digital twin tools, positioning the partners to assess how standardized nuclear solutions could support gigawatt-class, AI-ready data...

RCI Hospitality Holdings (RICK) FY 2025 earnings at a glance RCI Hospitality Holdings (RICK) has just posted its FY 2025 numbers with Q4 revenue of US$70.9 million and a basic EPS loss of US$0.63, set against trailing 12 month EPS of US$1.23 on revenue of US$279.4 million and earnings growth of 259.1% for the period. Over recent quarters, revenue has moved from US$73.2 million in Q4 2024 to US$71.5 million in Q1 2025, US$65.9 million in Q2, US$71.1 million in Q3 and US$70.9 million in Q4,...

If you are wondering whether Northern Oil and Gas at around US$28.84 is offering fair value or a potential mismatch between price and underlying worth, you are not alone. The stock has recent returns of 4.8% over 7 days, 5.4% over 30 days, 31.0% year to date and 2.4% over 1 year, which naturally raises questions about how much is already reflected in the price. Recent coverage has focused on Northern Oil and Gas in the context of its role within the broader energy sector and its position as...

Recent share performance and business snapshot Kering (ENXTPA:KER) has drawn investor attention after recent share price moves, with the stock showing a 0.7% gain over the past day but declines over the past week, month, and past 3 months. The group sits at around €28.7b in market value, anchored by brands such as Gucci, Saint Laurent, Bottega Veneta, and several jewelry and eyewear houses, and reports annual revenue of €14,675.0m. See our latest analysis for Kering. At a share price of...

Regulatory milestone and why it matters for TMC the metals (NasdaqGS:TMC) TMC the metals (NasdaqGS:TMC) is back in focus after the National Oceanic and Atmospheric Administration found its consolidated application for Clarion Clipperton Zone exploration and commercial recovery to be in substantial compliance with U.S. deep seabed regulations. See our latest analysis for TMC the metals. The regulatory progress arrives after a sharp reset in the share price, with a 36.25% 90 day share price...

In March 2026, Soleno Therapeutics updated its corporate bylaws, continued outreach with a CEO presentation at the Longwood Healthcare Leaders conference, and faced an investor class action lawsuit alleging inadequate disclosure of safety concerns around its Prader‑Willi syndrome therapy DCCR/Vykat XR. This combination of governance changes, legal scrutiny and discussion of a slower Vykat XR launch puts renewed focus on how safety perceptions and patient adoption may shape Soleno’s...